Home › Metastatic Cancer › North Carolina

Pag-aaral pangklinika para sa Metastatic Cancer sa North Carolina

52 pag-aaral para sa Metastatic Cancer ang naghahanap ng mga kalahok sa mga site sa North Carolina.

Mga Lungsod sa North Carolina

Opisyal na teksto ng pag-aaral (English)

BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)

Avenzo Therapeutics Recruiting Site, Chapel Hill

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07193511

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

FirstHealth of the Carolinas, Pinehurst

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07562152

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Cone Health MedCenter Asheboro, Asheboro
Cone Health Cancer Center at Alamance Regional, Burlington
Southeastern Medical Oncology Center-Clinton, Clinton
at 9 pa

Nagre-recruitPhase 2

Lahat ng edad · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05564377

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Carolina Cancer Research Center, Wilson

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06270706

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Duke University, Durham

Nagre-recruitPhase 1/2

Edad 12 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT04585750

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

University of North Carolina at Chapel Hill, Chapel Hill
Duke University Medical Center, Durham

Nagre-recruitPhase 2/3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT06943755

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Duke Cancer Center Cary, Cary
Duke Cancer Center - Investigational Chemotherapy Service, Durham
Duke Cancer Center, Durham
at 2 pa

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07222800

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

Duke Cancer Institute, Durham

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07007559

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Levine Children's Hospital- Pediatric Neuro-Oncology, Charlotte

Nagre-recruitPhase 1/2

Hanggang edad 25 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT04094610

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill
Levine Cancer Institute, Charlotte
University of North Carolina Hospitals at Hillsborough, Hillsborough

Nagre-recruitPhase 2/3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06989437

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

FirstHealth Cancer Center, Pinehurst
FirstHealth Moore Regional Hospital, Pinehurst
Carolina Cancer Research Center, Wilson

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07222566

A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

Atrium Health Levine Cancer Institute, Charlotte

Nagre-recruitPhase 1/2

Edad 12 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT05118789

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Duke Cancer Institute, Durham

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07213804

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Levine Cancer Institute, Charlotte
Oncology Specialists of Charlotte, Charlotte
Wake Forest Baptist Health, Winston-Salem

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07218380

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Messino Cancer Centers, Asheville
WakeMed Cancer Care - Waverly Hematology & Medical Oncology, Cary
University of North Carolina Medical Center, Chapel Hill
at 1 pa

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07174336

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Carolina Biooncology Institute, Huntersville

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT05267626

GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors

Carolina Biooncology Institute, Huntersville

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT04977453

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

University of North Carolina Medical Center, Chapel Hill
Duke Cancer Institute, Durham

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06119581

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer

Levine Cancer Institute, Charlotte

Nagre-recruitPhase 1/2

Edad 18 pataas · Kababaihan · Na-update Set 3, 2026 · NCT04802759

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Regional Medical Oncology Center_Wlson, Wilson

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT06072612

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

University of North Carolina (UNC) - Chapel Hill, Chapel Hill

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT05614739

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Duke University, Durham

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT05919264

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

Research Site, Greenville
Research Site, Pinehurst

Nagre-recruitPhase 3

Edad 18 pataas · Kababaihan · Na-update Hul 29, 2026 · NCT07044336

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

Investigative Site #131, Raleigh

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 23, 2026 · NCT06974110

PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival

Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill

Nagre-recruit

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 14, 2026 · NCT06896162

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

Duke Cancer Center, Durham

Nagre-recruitPhase 1

Edad 18 pataas · Kalalakihan · Na-update Hul 9, 2026 · NCT07103018

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

WakeMed Health & Hospitals, Cary

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 25, 2026 · NCT06216301

A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors

Exelixis Clinical Site #1, Hickory

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 24, 2026 · NCT06952010

REMASTer: REcurrent Brain Metastases After SRS Trial

Wake Forest Baptist Medical Center, Winston-Salem

Nagre-recruit

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 18, 2026 · NCT05124912

Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

W.G. Bill Hefner Medical Center, Salisbury

Nagre-recruitPhase 2

Edad 18 pataas · Kalalakihan · Na-update Hun 15, 2026 · NCT05422911

First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors

Research Site, Durham

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 12, 2026 · NCT07284186

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

Research Site, Durham

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 10, 2026 · NCT06835569

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Duke Cancer Center, Durham
Carolina BioOncology Institute, Huntersville

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 3, 2026 · NCT06040541

A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

Duke University Medical Center, Durham

Nagre-recruitPhase 1/2

Edad 12 pataas · Lahat ng kasarian · Na-update May 27, 2026 · NCT05384626

Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)

Carolina BioOncology Institute, Huntersville

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update May 19, 2026 · NCT05431270

UNC Childhood, Adolescent, and Young Adult Cancer Cohort

University of North Carolina at Chapel Hill, Chapel Hill

Nagre-recruitObservasyonal na pag-aaral

Edad 1 hanggang 39 · Lahat ng kasarian · Na-update May 12, 2026 · NCT05096923

UNC Metastatic Cancer Radiation Therapy Registry

Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill

Nagre-recruitObservasyonal na pag-aaral

Edad 18 pataas · Lahat ng kasarian · Na-update May 6, 2026 · NCT06306924

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

University of North Carolina at Chapel Hill, Chapel Hill

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 28, 2026 · NCT06413680

Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma

East Carolina University, Greenville

Nagre-recruitPhase 2/3

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 17, 2026 · NCT06947928

Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

Durham VA Medical Center, Durham, NC, Durham

Nagre-recruitPhase 2/3

Edad 18 pataas · Kalalakihan · Na-update Abr 8, 2026 · NCT04787744

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.